3 Medical Stocks to Consider as Markets Take a Breather

Amidst a market cooldown driven by new tariff hikes and a weaker July Jobs Report, prompting a search for defensive assets, the article highlights three medical sector stocks. CVS Health (CVS) is noted for its +30% year-to-date surge, 10x forward earnings, and 4.28% dividend yield, supported by strong earnings and raised guidance. Johnson & Johnson (JNJ) offers stability with a diversified model, 15.1x forward earnings, and a 3.16% dividend yield, having outperformed broader indexes this year. Tenet Healthcare (THC) stands out with a Zacks Rank #1, +25% year-to-date, 10x forward earnings, and significant positive earnings estimate revisions, projecting 25% EPS growth in fiscal 2025, offering defensive value in a volatile environment.

Analysis

Amidst increasing market volatility fueled by new tariff implementations and a weaker-than-expected July jobs report, a defensive rotation into the healthcare sector is being considered. The broader S&P 500 and Nasdaq indexes are showing signs of cooling after a significant three-month rally of over 10%, prompting a search for assets with non-cyclical demand. Within this context, three specific stocks are highlighted for their defensive characteristics and strong fundamentals. CVS Health (CVS) has demonstrated robust performance with a 30% year-to-date stock surge, supported by strong earnings and raised guidance, yet it maintains a value profile at a 10x forward P/E ratio and offers a significant 4.28% dividend yield. Johnson & Johnson (JNJ) presents a classic defensive value proposition, trading at a 15.1x forward earnings multiple with a 3.16% dividend yield; its stock has already outperformed the S&P 500 in 2025 with a 15% gain, benefiting from its highly diversified business model. Finally, Tenet Healthcare (THC) exhibits strong momentum, evidenced by its 25% year-to-date gain and a Zacks #1 (Strong Buy) rating, driven by substantial positive earnings estimate revisions. Its fiscal 2025 annual earnings are now projected to increase by 25% to $14.92 per share, with estimates having climbed 17% in the past 60 days, while still trading at an attractive 10x forward earnings.

Key Decisions for Investors

• Given the market pullback from recent highs and resurfacing macroeconomic concerns, investors should consider increasing exposure to defensive healthcare stocks to mitigate portfolio volatility.
• For income-focused investors, CVS Health and Johnson & Johnson offer compelling dividend yields of 4.28% and 3.16% respectively, combined with reasonable valuations that could provide a cushion during market downturns.
• Investors seeking growth at a reasonable price may find Tenet Healthcare attractive due to its strong upward earnings estimate revisions, with projected 25% EPS growth for fiscal 2025, suggesting potential for continued stock price appreciation.